First appraisal of brain pathology owing to A30P mutant alpha-synuclein

Ann Neurol. 2010 May;67(5):684-9. doi: 10.1002/ana.21966.


Familial Parkinson disease (PD) due to the A30P mutation in the SNCA gene encoding alpha-synuclein is clinically associated with PD symptoms. In this first pathoanatomical study of the brain of an A30P mutation carrier, we observed neuronal loss in the substantia nigra, locus coeruleus, and dorsal motor vagal nucleus, as well as widespread occurrence of alpha-synuclein immunopositive Lewy bodies, Lewy neurites, and glial aggregates. Alpha-synuclein aggregates ultrastructurally resembled Lewy bodies, and biochemical analyses disclosed a significant load of insoluble alpha-synuclein, indicating neuropathological similarities between A30P disease patients and idiopathic PD, with a more severe neuropathology in A30P carriers.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alanine / genetics
  • Brain / pathology*
  • Brain / ultrastructure
  • Brain Diseases / genetics*
  • Brain Diseases / pathology*
  • Family Health
  • Glial Fibrillary Acidic Protein / metabolism
  • Humans
  • Inclusion Bodies / pathology
  • Male
  • Mutation / genetics*
  • Proline / genetics
  • alpha-Synuclein / genetics*


  • Glial Fibrillary Acidic Protein
  • alpha-Synuclein
  • Proline
  • Alanine